New chair appointed for RPS Education and Standards Committee


Share post:

The Royal Pharmaceutical Society (RPS) has appointed Dr Anthony Cox from the University of Birmingham as the new chair of its Education and Standards Committee.

Anthony is Head of the School of Pharmacy and a Reader in Clinical Pharmacy and Drug Safety. He has previously been a member of the English Pharmacy Board and is a Fellow of the RPS.

The Education and Standards Committee provides expert advice and makes recommendations to the RPS Education and Professional Development directorate, reporting directly to the RPS Assembly.

Dr Anthony Cox said: “I’m looking forward to working with the committee during this vitally important time for the education of the profession at all levels, and delighted to support the RPS in continuing to develop and deliver its important role in defining and assuring post-registration standards of pharmacy practice.”

Claire Anderson, RPS president, said: “I’d like to congratulate Anthony on his appointment as the new Chair of the Education and Standards Committee. He brings a wealth of education experience to the role and will champion the Society’s important role in leading and supporting the profession to deliver and continually improve patient care through impactful post-registration education and standards.”


Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

Shadow Health Minister Preet Kaur Gill visits pharmacy in Staffordshire

Preet Kaur Gill, Shadow Minister for Primary Care and Public Health, has paid a recent visit to a...

Superdrug to halt single-use vape sales in UK, Ireland due to environmental concerns

British pharmacy chain Superdrug has announced plans to cease the sale of disposable vapes in all its UK...

Closure of temporary registers by 31 March 2024: GPhC

Pharmacists on the temporary register will be automatically removed on April 1, unless they have applied to rejoin the...

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...